Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) had its price target dropped by equities researchers at Citigroup from $8.00 to $5.00 in a report issued on Friday, FlyOnTheWall reports. Citigroup’s price target would suggest a potential upside of 167.38% from the stock’s current price. Separately, StockNews.com raised Lexicon Pharmaceuticals to a “sell” rating in a […]